The Lancet Publishes Two-Year Results of Abbott's Fully Bioabsorbable Drug Eluting Stent
- Details
- Category: Abbott
![Abbott Abbott](http://www.worldpharmanews.com/images/stories/logo/abbott.gif)
Sanofi-aventis invests â¬100 million in new facility in Mexico
- Details
- Category: Sanofi
![sanofi-aventis sanofi-aventis](http://www.worldpharmanews.com/images/stories/logo/sanofi-avenits.gif)
Roche Annual General Meeting: dividend raised by 9 percent
- Details
- Category: Roche
![Roche Roche](http://www.worldpharmanews.com/images/stories/logo/roche.gif)
Merck and Schering-Plough to Merge
- Details
- Category: Merck
![Merck & Co., Inc. Merck & Co., Inc.](http://www.worldpharmanews.com/images/stories/logo/merk.gif)
Roche increases offer price for Genentech shares to US$ 93 per share
- Details
- Category: Roche
![Roche Roche](http://www.worldpharmanews.com/images/stories/logo/roche.gif)
Lundbeck meets all of its financial forecasts for 2008 and expects continuing growth in 2009
- Details
- Category: Lundbeck
![H. Lundbeck A/S H. Lundbeck A/S](http://www.worldpharmanews.com/images/stories/logo/lundbeck.gif)
New diagnostic tool for Hypoactive Sexual Desire Disorder (HSDD) in women
- Details
- Category: Boehringer Ingelheim
![Boehringer Ingelheim Boehringer Ingelheim](http://www.worldpharmanews.com/images/stories/logo/boehringeringelheim.gif)
More Pharma News ...
- Pfizer Expands Portfolio of Generic Medicines in the U.S. and Europe
- AstraZeneca and MAP Pharmaceuticals, Inc. Announce Worldwide Collaboration
- Advances in Renal Cancer Journalists' Award
- Novartis shareholders approved 25% dividend increase
- Abbott Successfully Completes Tender Offer for Shares of Advanced Medical Optics
- Pfizer Discontinues Development of Two Phase 3 Compounds
- Nycomed reports a satisfactory 2008